CTSU CALGB 80702. A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.
Esther Rehmus, MD
McDowell Cancer Research at 330-344-6348
13026. Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Scott McGee, MD
McDowell Cancer Research at 330-344-6348.
SWOG 1406. Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Akron General Medical Center 1 Akron General Avenue (Formerly 400 Wabash Avenue) Akron, OH 44307 330-344-6000 1-800-221-4601 © 2014 Akron General Health System
This site complies with the HONcode standard for trustworthy health information: verify here.